Pankaj Ranjan Karn
Head of Complex Formulation Division @ Dongkook Pharm.
About
Specialities: • Pharmaceutical professional having BPharm, MPharm (Pharmaceutics) and PhD in Pharmaceutics (Korea) with an award from the Ministry of Education, Science and Technology (Korea) • Expertise in novel drug delivery technologies, namely liposomes, SNEDDS, solid dispersion, etc. and exposure to development and commercialization of pharmaceutical products using these technologies • Expertise in manufacturing liposomes using a specialized large scale up ‘supercritical anti-solvent’ technique • Experience of handing basic and advanced characterization tools for liposomes, emulsions and nanoparticles as well as animals for in vivo studies. • Work experience in both pharmaceutical company as well as academic institutions (lecturer, researcher, postdoc researcher) • Successfully developed generics, supergenerics (added value generics) in oral solid and liquid dosage forms, and working with the fixed dose combination products (IMD) in capsule and tablet dosage forms as well as the new drug development in the liquid dosage form. • Experience in formulation and development of ODT; knowledge and understanding of KFDA guidelines for drug approvals in Korea • Expertise in preparing regulatory documents (CTD or other technical documents) and experience of writing CTD for exporting products to various countries. • Proven ability to communicate seamlessly with various global partners such as CMOs, CROs, big pharma etc. as a part of collaboration or co-development program • Leading efficiently a part of formulation research team • 6 First Author SCI publications, 2 patents registered in Korea, and an author of a chapter of an eBook published from the Future Medicine Group • An excellent command and proficient in spoken and written Korean and acquired a Permanent Residency Visa (F-5) in Korea in 2016 • Maintain a multidisciplinary professional networks mainly in India and Korea
South Korea
Gyeonggi
Pharmaceuticals
Microsoft Word, Nanoparticles, Drug Delivery, HPLC, Liposomes, Powder X-ray Diffraction, Pharmaceutics, Nanotechnology, Supercritical Fluids, In Vivo, In Vitro, Scanning Electron Microscopy, Drug Development, GMP, Research, Pharmaceutical Industry, Formulation, Targeted Drug Delivery, Coatings, Zeta Potential
Experience

Head of Complex Formulation Division
Dongkook Pharmaceutical Co Ltd
Suwon, Gyeonggi-do, Korea
Leading the development of complex injectable formulations, including microspheres, liposomes, and advanced drug delivery systems (LNPs), for both Korean and global markets. Spearheading innovative projects from early-stage formulation to clinical translation, focusing on differentiated NDA 505(b)(2) long-acting injectables and related therapies. Oversee multidisciplinary teams and collaborate with global partners to advance strategic development, regulatory submission, and market entry.

Senior Manager, Formulation Research Team
Yongin, Gyeonggi, South Korea
Core responsibility - Intranasal Formulations (Nasal Spray), Device development and Drug-device combination product - Psychedelic Drug Development - Modified/extended-release formulations (oral solids, microspheres, TDS, liposomes) Additional responsibility - Microneedles - Nucleic Acid Therapeutics (mRNA-LNPs, Exosomes) - DW Overseas R&Ds (India, Indonesia & China) Management [Co-development Program]

Team Leader (Senior Manager), Formulation Research II Team
Gyeonggi, South Korea
Lead a Formulation team on NDA 505(b)(2) [extended/Modified-release (differentiated) products)] & ANDA projects in different dosage forms - ER tablets, microspheres long-acting injectable depot, transdermal patches, etc. Lead clinical studies (India & Europe) with TDS and microspheres and lead regulatory communications (INDs, Pre-IND meetings, SA, consultancy, etc.), manage communication with the business partners.

Team Leader, Formulation Team
Suwon, Gyeonggi-do, Korea
Lead a Formulation Team on NDA, Generic, and modified generic products for MFDS and EU Submissions Lead the clinical (Pilot BA/BE) Studies, support the Phase I and Phase III studies Manage the global connectivity and point of contact for Alvogen Korea R&D

Senior Specialist I (차장) - Formulation Team
Suwon, Gyeonggi-do, Korea
Formulation and Process development of - Generics, Value-added/differentiated generics (oral solids & soft capsules) for MFDS Submission - Combination Products (soft capsules) - New drug (peptides) for ophthalmic applications Open innovation/Collaborative work with major Pharma

Postdoctoral Researcher
Songdo-dong, Incheon, Korea
Core areas: Liposomal formulations (thin film, ethanol Inj.), solid-lipid nanoparticles formulations Liposomal preparation using supercritical fluid methods Small-scale and pilot-scale manufacture Pre-clinical studies Conventional dosage forms (modified release formulations) Manuscript writing, communication & co-development
Education

Drug Delivery Systems
Dissertation title: Development of a novel liposomal cyclosporin A using supercritical fluid method for the ophthalmic application. Supervisor: Professor Sung-Joo Hwang, Yonsei University Co-supervisor: Prof. Jeong-Sook Park, Chungnam National University
Pankaj Ranjan Karn's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.






